The choice of immunosuppressive therapy depending on the level of anti-HLA antibodies in kidney transplantation

The choice of immunosuppressive therapy depending on the level of anti-HLA antibodies in kidney transplantation

Seeking to develop immunosuppression regimens that would take into account the patient's level of sensitization to the antigens of the main histocompatibility complex, we studied 123 patients after kidney transplantation. Depending on the choice of immunosuppressive therapy, two groups were for...

Full description

Bibliographic Details
Main Authors:	N. V. Borovkova, A. V. Pinchuk, N. V. Shmarina, N. V. Doronina, R. V. Storozhev
Format:	Article
Language:	English
Published:	N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department 2018-03-01
Series:	Трансплантология (Москва)
Subjects:	kidney transplantation hla antibodies immunosuppression therapy
Online Access:	https://www.jtransplantologiya.ru/jour/article/view/214

Similar Items

IMPORTANCE OF RESEARCH HLA ANTIBODIES CLASS I AND II, AND MICA ANTIBODIES IN KIDNEY TRANSPLANTATION
by: M. Sh. Khubutia, et al.
Published: (2011-12-01)

HLA antibodies and their value during renal transplantation
by: M. Sh. Khubutia, et al.
Published: (2018-08-01)

Significance of pretransplant and de novo anti-HLA antibody detection after simultaneous pancreas-kidney transplantation
by: I. V. Dmitriev, et al.
Published: (2022-09-01)

Diagnostic value of anti-HLA antibody monitoring in the diagnosis of immunological complications following kidney transplantation
by: V. O. Aleksandrova, et al.
Published: (2024-09-01)

Experience of using polymethyl methacrylate membranes for anti-HLA antibodies’ elimination by hemodialysis in renal transplant recipients
by: E. I. Pervakova, et al.
Published: (2019-09-01)

Intermediate steroid withdrawal after renal transplantation and anti-HLA antibodies (HLA-Abs) development
by: Elena Monfá, et al.
Published: (2017-07-01)

SUCCESSFUL ABO-INCOMPATIBLE KIDNEY TRANSPLANTATION FROM LIVING-RELATED DONOR IN HIGH-SENSITIZED PATIENT
by: A. I. Sushkov, et al.
Published: (2012-05-01)

Optimized immunosuppression to prevent graft failure in renal transplant recipients with HLA antibodies (OuTSMART): a randomised controlled trialResearch in context
by: Dominic Stringer, et al.
Published: (2023-02-01)

Non-HLA Antibodies and Epitope Mismatches in Kidney Transplant Recipients With Histological Antibody-Mediated Rejection
by: Marta Crespo, et al.
Published: (2021-07-01)

Anti-HLA antibody repertoire after IVIg infusion in highly sensitized patients waiting for kindney transplantation
by: V Aubert, et al.
Published: (2006-11-01)

Non-HLA Antibodies in Kidney Transplantation: Immunity and Genetic Insights
by: Bogdan Marian Sorohan, et al.
Published: (2022-06-01)

The effect of pre-existing HLA sensitization on the renal allograft function according to angionephroscintigraphy results
by: O. G. Sinyakova, et al.
Published: (2018-03-01)

Impact of Preformed Donor-Specific Anti-HLA-Cw and Anti-HLA-DP Antibodies on Acute Antibody-Mediated Rejection in Kidney Transplantation
by: Timothée Laboux, et al.
Published: (2023-11-01)

Methods to determine the sensitization to HLA in the recipients on the waiting list for organ transplantation
by: N. V. Borovkova, et al.
Published: (2018-08-01)

Induction immunosuppression in kidney transplantation: Thymoglobulin® (a literature review)
by: A. V. Pinchuk
Published: (2016-02-01)

Low-dose alemtuzumab induction in a tailored immunosuppression protocol for sensitized kidney transplant recipients
by: Martina Guthoff, et al.
Published: (2020-05-01)

Case report on prolonged kidney graft survival without immunosuppressive therapy after allogeneic hematopoietic stem cell transplantation
by: N. V. Shmarina, et al.
Published: (2024-01-01)

Immunosenescence as a reason of individualizing immunosuppressive therapy in kidney transplantation
by: V. A. Fedulkina, et al.
Published: (2021-09-01)

Immunosuppressive Therapy Protocols in Kidney Transplantation in Adults
by: Jasenko Karamehić, et al.
Published: (2006-08-01)

The Pre-Transplant Non-HLA Antibody Burden Associates With the Development of Histology of Antibody-Mediated Rejection After Kidney Transplantation
by: Aleksandar Senev, et al.
Published: (2022-02-01)

Misidentification of preformed anti-HLA-DP antibodies leads to antibody-mediated kidney transplant rejection: a case report
by: Duangtawan Thammanichanond, et al.
Published: (2022-05-01)

The dynamics of pre-existing anti-HLA antibodies and the results of kidney transplantation
by: A. V. Vatazin, et al.
Published: (2018-09-01)

The use of belatacept in kidney transplantation
by: N. N. Babenko, et al.
Published: (2018-09-01)

Extended genomic HLA typing identifies previously unrecognized mismatches in living kidney transplantation
by: Claudia Lehmann, et al.
Published: (2023-01-01)

Comparison of quality of life in patients after kidney transplantation under different regimens of immunosuppressive therapy
by: E. V. Parabina, et al.
Published: (2025-01-01)

DIFFERENTIAL IMPACT OF HLA-A, HLA-B AND HLA-DR COMPATIBILITY ON THE RENAL ALLOGRAFT SURVIVAL
by: V. Y. Abramov, et al.
Published: (2012-09-01)

Experience of using advagraf after kidney transplantation in the Sklifosofsky Research Institute for Emergency Medicine
by: A. V. Pinchuk, et al.
Published: (2016-01-01)

Sex-Specific Differences in HLA Antibodies after Pneumococcal Vaccination in Kidney Transplant Recipients
by: Monika Lindemann, et al.
Published: (2019-08-01)

Editorial: A hill of needs: Non-HLA antibodies and transplantation
by: H.G. Otten, et al.
Published: (2022-08-01)

Preventing kidney transplant failure by screening for antibodies against human leucocyte antigens followed by optimised immunosuppression: OuTSMART RCT
by: Stringer Dominic, et al.
Published: (2023-09-01)

Development and Validation of a Multiplex Non-HLA Antibody Assay for the Screening of Kidney Transplant Recipients
by: Elena G. Kamburova, et al.
Published: (2018-12-01)

Circulating Donor-Specific Anti-HLA Antibodies Associate With Immune Activation Independent of Kidney Transplant Histopathological Findings
by: Elisabet Van Loon, et al.
Published: (2022-02-01)

Clinical relevance of HLA-DQ eplet mismatch and maintenance immunosuppression with risk of allosensitization after kidney transplant failure
by: Jenny Tran, et al.
Published: (2024-04-01)

OCULAR PATHOLOGY IN PATIENTS AFTER KIDNEY TRANSPLANTATION
by: L. K. Moshetova, et al.
Published: (2011-12-01)

Donor/Recipient HLA Molecular Mismatch Scores Predict Primary Humoral and Cellular Alloimmunity in Kidney Transplantation
by: Maria Meneghini, et al.
Published: (2021-03-01)

THE ROLE OF PRE-TRANSPLANT AND DE NOVO ALLOANTIBODIES IN KIDNEY TRANSPLANTATION
by: A. I. Sushkov, et al.
Published: (2011-06-01)

Everolimus plus reduced calcineurin inhibitor prevents de novo anti-HLA antibodies and humoral rejection in kidney transplant recipients: 12-month results from the ATHENA study
by: Wolfgang Arns, et al.
Published: (2023-10-01)

Dampened Inflammatory Signalling and Myeloid-Derived Suppressor-Like Cell Accumulation Reduces Circulating Monocytic HLA-DR Density and May Associate With Malignancy Risk in Long-Term Renal Transplant Recipients
by: Matthew J. Bottomley, et al.
Published: (2022-07-01)

The effect of the applied induction immunosuppressive therapy protocol on the allografted kidney condition
by: V. A. Goryaynov, et al.
Published: (2017-03-01)

Prevalence of pre-transplant anti-HLA antibodies and their impact on outcomes in lung transplant recipients
by: Ji Eun Park, et al.
Published: (2018-03-01)